Nutra Pharma Corp (NPHC) Asset Utilization Ratio (2011 - 2026)

Nutra Pharma has disclosed Asset Utilization Ratio across 15 years of filings, most recently posting 0.26 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio fell 32.76% year-over-year to 0.26; the TTM figure through Jun 2026 stood at 0.26 (down 32.76% YoY), while the FY2025 annual figure was 0.42, up 6.11% from the prior year.
• Asset Utilization Ratio came in at 0.26 for Q2 2026 at Nutra Pharma, down from 0.34 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q4 2024 to a low of 0.11 in Q2 2022.
• Average Asset Utilization Ratio over 5 years is 0.29, with a median of 0.3 recorded in 2023.
• Year-over-year, Asset Utilization Ratio surged 153.82% in 2023 and tumbled 32.76% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.2 in 2022, then soared by 50.78% to 0.3 in 2023, then surged by 39.83% to 0.43 in 2024, then fell by 9.08% to 0.39 in 2025, then slumped by 32.89% to 0.26 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.26 in Q2 2026, 0.34 in Q1 2026, and 0.39 in Q4 2025.